A strain comparison of Campylobacter isolated from retail poultry and human clinical cases in Atlantic Canada.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 20 12 2018
accepted: 10 04 2019
entrez: 9 5 2019
pubmed: 9 5 2019
medline: 14 1 2020
Statut: epublish

Résumé

Campylobacter is the leading cause of food-borne bacterial disease in Canada and many developed countries. One of the most common sources of human campylobacteriosis is considered to be the consumption or handling of raw or undercooked poultry. To date, few Canadian studies have investigated both the prevalence of Campylobacter on retail poultry and its potential impact on human clinical cases. The objective of this study was to evaluate the prevalence of Campylobacter spp. at the retail level and the correlation between subtypes recovered from chicken and those recovered from human clinical cases within the province of Nova Scotia, Canada. From this study 354 human clinical isolates were obtained from provincial hospital laboratories and a total of 480 packages of raw poultry cuts were sampled from retail outlets, yielding 312 isolates (65%), of all which were subtyped using comparative genomic fingerprinting (CGF). Of the 312 chicken isolates, the majority of isolates were C. jejuni (91.7%), followed by C. coli (7.7%) and C. lari (0.6%). Using CGF to subtype C. jejuni and C. coli isolates, 99 and 152 subtypes were recovered from chicken and clinical cases, respectively. The most prevalent human and chicken subtypes found in NS are similar to those observed nationally; indicating that the Campylobacter from this study appear to reflect of the profile of Campylobacter subtypes circulating nationally. Of the subtypes observed, only 36 subtypes were common between the two groups, however, these subtypes represented 48.3% of the clinical isolates collected. The findings from this study provides evidence that in Nova Scotia, retail poultry can act as a reservoir for Campylobacter subtypes that have been implicated in human illness.

Identifiants

pubmed: 31067242
doi: 10.1371/journal.pone.0215928
pii: PONE-D-18-36383
pmc: PMC6505856
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0215928

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Food Prot. 2007 Feb;70(2):355-62
pubmed: 17340869
J Microbiol Methods. 2013 Oct;95(1):24-31
pubmed: 23871858
J Clin Microbiol. 2012 Mar;50(3):788-97
pubmed: 22170908
J Microbiol Methods. 2012 Dec;91(3):506-13
pubmed: 22985716
J Food Prot. 2014 Oct;77(10):1682-8
pubmed: 25285484
J Clin Microbiol. 2008 Oct;46(10):3404-11
pubmed: 18701662
J Clin Microbiol. 2013 Jan;51(1):195-201
pubmed: 23115263
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
PLoS One. 2013 Nov 14;8(11):e81796
pubmed: 24244747
Foodborne Pathog Dis. 2013 Jul;10(7):639-48
pubmed: 23659355
Food Microbiol. 2014 Dec;44:258-63
pubmed: 25084671
Epidemiol Infect. 2017 Jan;145(2):299-309
pubmed: 27766988
J Food Prot. 2012 Jan;75(1):34-40
pubmed: 22221353
J Clin Microbiol. 2017 May;55(5):1269-1275
pubmed: 28249998
Can Vet J. 2009 Feb;50(2):173-8
pubmed: 19412397
Prev Vet Med. 2006 Jun 16;74(4):264-78
pubmed: 16430979
Methods Mol Biol. 2017;1512:9-18
pubmed: 27885594
Epidemiol Infect. 2010 Dec;138(12):1695-703
pubmed: 20334726
Foodborne Pathog Dis. 2014 Feb;11(2):150-5
pubmed: 24219173
Risk Anal. 2017 Apr;37(4):677-715
pubmed: 27641939
Epidemiol Infect. 2010 Oct;138(10):1372-83
pubmed: 20141645
Epidemiol Infect. 2013 Aug;141(8):1625-39
pubmed: 23013659
J Food Prot. 2009 Sep;72(9):1963-76
pubmed: 19777901
Epidemiol Infect. 2011 Jun;139(6):937-45
pubmed: 20731884
J Clin Microbiol. 1997 Oct;35(10):2568-72
pubmed: 9316909
BMC Genomics. 2011 Nov 28;12:584
pubmed: 22122991
J Med Microbiol. 2005 Nov;54(Pt 11):1043-1047
pubmed: 16192435
Prev Vet Med. 2010 Jan 1;93(1):33-41
pubmed: 19837471
Emerg Infect Dis. 1999 Jan-Feb;5(1):28-35
pubmed: 10081669
PLoS One. 2017 Aug 24;12(8):e0183790
pubmed: 28837643
BMC Evol Biol. 2008 Aug 08;8:229
pubmed: 18691421
Int J Food Microbiol. 2017 Jul 17;253:43-47
pubmed: 28477522
Front Microbiol. 2017 May 30;8:954
pubmed: 28611753
J Clin Microbiol. 2012 Mar;50(3):798-809
pubmed: 22162562
J Appl Microbiol. 2010 Mar;108(3):868-877
pubmed: 19709341
J Food Prot. 2006 Sep;69(9):2176-82
pubmed: 16995521
PLoS One. 2013 Dec 26;8(12):e83731
pubmed: 24386265
ISME J. 2016 Mar;10(3):721-9
pubmed: 26305157
Clin Infect Dis. 2009 Apr 15;48(8):1072-8
pubmed: 19275496
Emerg Infect Dis. 2012 Feb;18(2):226-33
pubmed: 22304786
J Clin Microbiol. 2005 Mar;43(3):1105-11
pubmed: 15750069
Vet Microbiol. 2015 Jul 9;178(1-2):94-8
pubmed: 25960333
Vet Res. 2005 May-Jun;36(3):351-82
pubmed: 15845230
PLoS Med. 2015 Dec 03;12(12):e1001921
pubmed: 26633831

Auteurs

Lisa M Hodges (LM)

Canadian Food Inspection Agency, Dartmouth, Nova Scotia, Canada.

Catherine D Carrillo (CD)

Canadian Food Inspection Agency, Ottawa Laboratory (Carling), Ottawa, Ontario, Canada.

Jacqueline P Upham (JP)

Canadian Food Inspection Agency, Dartmouth, Nova Scotia, Canada.

Antonela Borza (A)

Canadian Food Inspection Agency, Dartmouth, Nova Scotia, Canada.

Mikaela Eisebraun (M)

Canadian Food Inspection Agency, Dartmouth, Nova Scotia, Canada.

Robyn Kenwell (R)

Bureau of Microbial Hazards, Food Directorate, Health Canada, Ottawa, Ontario, Canada.

Steven K Mutschall (SK)

National Microbiology Laboratory at Lethbridge, Public Health Agency of Canada, Lethbridge, Alberta, Canada.

David Haldane (D)

Queen Elizabeth II Health Sciences Centre, Mackenzie Building, Halifax, Nova Scotia.

Emily Schleihauf (E)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Eduardo N Taboada (EN)

National Microbiology Laboratory at Lethbridge, Public Health Agency of Canada, Lethbridge, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH